Clinical Trial Update: A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial investigates whether tumor hENT1 status predicts gemcitabine response and whether the FOLFOX regimen is more effective than gemcitabine in metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Gemcitabine (Gemcitabine)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Metastatic Pancreas Cancer | Phase 3 | Status: UNKNOWN